BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11934096)

  • 1. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
    J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
    J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
    Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
    Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
    Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
    AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
    Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
    Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency thermal ablation of hepatocellular carcinoma: using contrast-enhanced harmonic power doppler sonography to assess treatment outcome.
    Cioni D; Lencioni R; Rossi S; Garbagnati F; Donati F; Crocetti L; Bartolozzi C
    AJR Am J Roentgenol; 2001 Oct; 177(4):783-8. PubMed ID: 11566673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic response evaluation of malignant hepatic masses treated by interventional procedures with contrast-enhanced agent detection imaging.
    Youk JH; Lee JM; Kim CS
    J Ultrasound Med; 2003 Sep; 22(9):911-20. PubMed ID: 14510262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
    Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
    J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small hepatocellular carcinoma: therapeutic effectiveness of percutaneous radio frequency ablation therapy with a LeVeen needle electrode.
    Shirato K; Morimoto M; Tomita N; Kokawa A; Sugimori K; Saito T; Numata K; Sekihara H; Tanaka K
    J Ultrasound Med; 2002 Jan; 21(1):67-76. PubMed ID: 11794405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
    Cedrone A; Pompili M; Sallustio G; Lorenzelli GP; Gasbarrini G; Rapaccini GL
    Am J Gastroenterol; 2001 Jun; 96(6):1854-9. PubMed ID: 11419839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.
    Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Kim SK; Jang KM; Lee JY; Lim JH
    Korean J Radiol; 2004; 5(3):185-98. PubMed ID: 15467416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma treated with radio-frequency ablation: spectrum of imaging findings.
    Kim SK; Lim HK; Kim YH; Lee WJ; Lee SJ; Kim SH; Lim JH; Kim SA
    Radiographics; 2003; 23(1):107-21. PubMed ID: 12533646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radio-frequency ablation of hepatic metastases: postprocedural assessment with a US microbubble contrast agent--early experience.
    Solbiati L; Goldberg SN; Ierace T; Dellanoce M; Livraghi T; Gazelle GS
    Radiology; 1999 Jun; 211(3):643-9. PubMed ID: 10352586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation.
    Morimoto M; Nozawa A; Numata K; Shirato K; Sugimori K; Kokawa A; Tomita N; Saitou T; Nakatani Y; Imada T; Tanaka K
    J Ultrasound Med; 2005 Mar; 24(3):273-83. PubMed ID: 15723840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China.
    Lu MD; Yu XL; Li AH; Jiang TA; Chen MH; Zhao BZ; Zhou XD; Wang JR
    Ultrasound Med Biol; 2007 Nov; 33(11):1736-49. PubMed ID: 17629608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract.
    Choi D; Lim HK; Kim MJ; Kim SH; Lee WJ; Kim SH; Lim JH; Paik SW; Koh KC; Yoo BC
    AJR Am J Roentgenol; 2004 Nov; 183(5):1417-24. PubMed ID: 15505314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
    Du J; Li HL; Zhai B; Chang S; Li FH
    Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous sonographically guided saline-enhanced radiofrequency ablation of hepatocellular carcinoma.
    Giorgio A; Tarantino L; de Stefano G; Scala V; Liorre G; Scarano F; Perrotta A; Farella N; Aloisio V; Mariniello N; Coppola C; Francica G; Ferraioli G
    AJR Am J Roentgenol; 2003 Aug; 181(2):479-84. PubMed ID: 12876030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.